CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-01 | Bergstrom Donald A President, R&D | Sale | −8,100 | $23.07 | $187K | 89,659 |
| 2022-09-01 | Bergstrom Donald A President, R&D | Option exercise · Stock Option (Right to Buy) | −8,100 | 139,356 | ||
| 2022-08-24 | Bergstrom Donald A President, R&D | Option exercise | +15,000 | $4.12 | $62K | 104,659 |
| 2022-08-24 | Bergstrom Donald A President, R&D | Sale | −15,000 | $25.00 | $375K | 89,659 |
| 2022-08-24 | Bergstrom Donald A President, R&D | Option exercise · Stock Option (Right to Buy) | −15,000 | 147,456 | ||
| 2022-08-05 | Bergstrom Donald A President, R&D | Option exercise | +8,000 | $4.12 | $33K | 97,659 |
| 2022-08-05 | Bergstrom Donald A President, R&D | Sale | −8,000 | $20.00 | $160K | 89,659 |
| 2022-08-05 | Bergstrom Donald A President, R&D | Option exercise · Stock Option (Right to Buy) | −8,000 | 162,456 | ||
| 2022-07-28 | Porter Andy Chief Administrative Officer | Sale | −452 | $21.27 | $10K | 45,871 |
| 2022-07-28 | Catinazzo Thomas Chief Financial Officer | Sale | −734 | $21.26 | $16K | 52,218 |
| 2022-07-28 | Bergstrom Donald A President, R&D | Sale | −1,835 | $21.27 | $39K | 89,659 |
| 2022-07-28 | Adams Brian Chief Legal Officer | Sale | −734 | $21.27 | $16K | 62,842 |
| 2022-07-25 | Kathiresan Sekar Director | Grant or award · Stock Option (Right to Buy) | +71,881 | 71,881 | ||
| 2022-07-06 | Bergstrom Donald A President, R&D | Option exercise | +8,000 | $4.12 | $33K | 99,494 |
| 2022-07-06 | Bergstrom Donald A President, R&D | Sale | −8,000 | $20.00 | $160K | 91,494 |
| 2022-07-06 | Bergstrom Donald A President, R&D | Option exercise · Stock Option (Right to Buy) | −8,000 | 170,456 | ||
| 2022-06-30 | Patel Sanjiv President and CEO | Grant or award | +814 | $14.24 | $12K | 254,554 |
| 2022-06-27 | Porter Andy Chief Administrative Officer | Sale | −265 | $20.31 | $5K | 46,323 |
| 2022-06-27 | Catinazzo Thomas Chief Financial Officer | Sale | −300 | $20.31 | $6K | 52,952 |
| 2022-06-27 | Adams Brian Chief Legal Officer | Sale | −300 | $20.31 | $6K | 63,576 |
Page 18 of 27 · 534 trades